Intelligent Bio Solutions Files 8-K
Ticker: INBS · Form: 8-K · Filed: Aug 6, 2025 · CIK: 1725430
Sentiment: neutral
Topics: 8-K, filing, corporate-update
TL;DR
IBSI filed an 8-K on Aug 6th, check for updates.
AI Summary
Intelligent Bio Solutions Inc. filed an 8-K on August 6, 2025, reporting on other events and financial statements. The company, formerly known as GBS Inc., is incorporated in Delaware and headquartered in New York.
Why It Matters
This filing provides updates on the company's activities and financial status, which are important for investors to monitor.
Risk Assessment
Risk Level: low — This is a routine filing with no immediate negative or positive indicators.
Key Players & Entities
- Intelligent Bio Solutions Inc. (company) — Registrant
- GBS Inc. (company) — Former company name
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (company) — Previous former company name
- August 6, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, covering Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
When was the report filed?
The report was filed on August 6, 2025.
What were the previous names of Intelligent Bio Solutions Inc.?
The company was formerly known as GBS Inc. and prior to that, Glucose Biosensor Systems (Greater China) Holdings, Inc.
Where is Intelligent Bio Solutions Inc. headquartered?
The company's principal executive offices are located at 135 West 41st Street, 5th Floor, New York, NY 10036.
What is the company's Standard Industrial Classification code?
The company's SIC code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 6, 2025 regarding INTELLIGENT BIO SOLUTIONS INC. (INBS).